| Primary |
| Hypertension |
76.1% |
| Diabetes Mellitus |
6.8% |
| Blood Pressure |
3.0% |
| Depression |
1.3% |
| Cardiac Disorder |
1.2% |
| Pain |
1.2% |
| Blood Cholesterol |
1.1% |
| Essential Hypertension |
1.0% |
| Type 2 Diabetes Mellitus |
0.9% |
| Blood Cholesterol Increased |
0.8% |
| Thyroid Disorder |
0.8% |
| Blood Pressure Abnormal |
0.8% |
| Hypothyroidism |
0.8% |
| Asthma |
0.7% |
| Anticoagulant Therapy |
0.7% |
| Sleep Disorder |
0.6% |
| Cardiovascular Disorder |
0.5% |
| Hypercholesterolaemia |
0.5% |
| Osteoporosis |
0.5% |
| Diuretic Therapy |
0.5% |
|
| Death |
23.4% |
| Oedema Peripheral |
7.4% |
| Hypertension |
7.2% |
| Cerebrovascular Accident |
6.5% |
| Blood Pressure Increased |
6.4% |
| Myocardial Infarction |
4.9% |
| Diabetes Mellitus |
3.9% |
| Infarction |
3.9% |
| Surgery |
3.7% |
| Hypotension |
3.6% |
| Pneumonia |
3.6% |
| Wrong Technique In Drug Usage Process |
3.5% |
| Vomiting |
3.2% |
| Fall |
3.1% |
| Renal Disorder |
3.0% |
| Blood Pressure Inadequately Controlled |
2.6% |
| Renal Failure |
2.6% |
| Swelling |
2.6% |
| Weight Decreased |
2.6% |
| Malaise |
2.5% |
|
| Secondary |
| Hypertension |
64.7% |
| Diabetes Mellitus |
8.5% |
| Product Used For Unknown Indication |
6.5% |
| Blood Pressure |
2.7% |
| Pain |
2.1% |
| Drug Use For Unknown Indication |
2.0% |
| Cardiac Failure |
1.4% |
| Cardiac Disorder |
1.3% |
| Atrial Fibrillation |
1.2% |
| Osteoporosis |
1.2% |
| Sleep Disorder |
1.2% |
| Blood Cholesterol Increased |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
| Blood Cholesterol |
0.9% |
| Depression |
0.8% |
| Gastritis |
0.8% |
| Thyroid Disorder |
0.8% |
| Asthma |
0.7% |
| Constipation |
0.7% |
| Hypercholesterolaemia |
0.7% |
|
| Death |
11.2% |
| Wrong Technique In Drug Usage Process |
10.4% |
| Blood Pressure Increased |
8.9% |
| Oedema Peripheral |
8.2% |
| Hypertension |
6.7% |
| Tremor |
5.6% |
| Renal Failure Acute |
5.2% |
| Weight Increased |
4.5% |
| Drug Ineffective |
4.1% |
| Renal Disorder |
4.1% |
| Vomiting |
4.1% |
| Dizziness |
3.7% |
| Myocardial Infarction |
3.3% |
| Renal Failure |
3.3% |
| Blood Pressure Inadequately Controlled |
3.0% |
| Memory Impairment |
3.0% |
| Weight Decreased |
3.0% |
| Headache |
2.6% |
| Malaise |
2.6% |
| Renal Impairment |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.8% |
| Hypertension |
20.8% |
| Drug Use For Unknown Indication |
10.9% |
| Diabetes Mellitus |
3.6% |
| Rheumatoid Arthritis |
3.5% |
| Blood Cholesterol Increased |
3.1% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Pain |
2.9% |
| Hepatitis C |
2.8% |
| Type 2 Diabetes Mellitus |
2.5% |
| Prophylaxis |
2.1% |
| Atrial Fibrillation |
2.0% |
| Osteoporosis |
1.8% |
| Depression |
1.7% |
| Blood Pressure |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Hyperlipidaemia |
1.3% |
| Cardiac Disorder |
1.2% |
| Asthma |
1.2% |
| Hypercholesterolaemia |
1.1% |
|
| Flushing |
12.1% |
| Pruritus |
7.3% |
| Nausea |
6.5% |
| Vomiting |
5.9% |
| Rash |
5.1% |
| Pain In Extremity |
4.9% |
| Drug Ineffective |
4.6% |
| Paraesthesia |
4.6% |
| Weight Decreased |
4.6% |
| Hypertension |
4.3% |
| Muscle Spasms |
4.3% |
| Myocardial Infarction |
4.3% |
| Pain |
4.3% |
| Depression |
4.0% |
| Malaise |
4.0% |
| Pyrexia |
4.0% |
| Somnolence |
4.0% |
| Headache |
3.8% |
| Vision Blurred |
3.8% |
| Pneumonia |
3.5% |
|
| Interacting |
| Hypertension |
49.2% |
| Neuroborreliosis |
10.2% |
| Diabetes |
6.8% |
| Diverticulum |
5.1% |
| Cardiac Failure Congestive |
3.4% |
| Depression |
3.4% |
| Essential Hypertension |
3.4% |
| Peripheral Arterial Occlusive Disease |
3.4% |
| Blood Pressure High |
1.7% |
| Diabetes Mellitus |
1.7% |
| Hyperuricaemia |
1.7% |
| Ischaemic Cardiomyopathy |
1.7% |
| Nerve Compression |
1.7% |
| Osteoporosis |
1.7% |
| Pain |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
|
| Suicidal Ideation |
47.4% |
| Syncope |
15.8% |
| Pain In Extremity |
10.5% |
| Abdominal Pain |
5.3% |
| Disorientation |
5.3% |
| Drug Interaction |
5.3% |
| Drug Intolerance |
5.3% |
| Fatigue |
5.3% |
|
